The DOI matches its Crossref record.
Chronic obstructive pulmonary disease and cardiovascular risk: Insights from the NAVIGATOR trial
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chronic obstructive pulmonary disease (COPD) and CVD are often comorbid because of the common risk factor of smoking.
“However, chronic obstructive pulmonary disease (COPD) and CVD are often comorbid because of the common risk factor of smoking, and the presence of COPD in current or former smokers is an independent predictor of overall cardiovascular events (13).”
From Updating ACSM's Recommendations for Exercise Preparticipation Health Screening (2015) · cites this paper as [13]
The presence of COPD in current or former smokers is an independent predictor of overall cardiovascular events.
“However, chronic obstructive pulmonary disease (COPD) and CVD are often comorbid because of the common risk factor of smoking, and the presence of COPD in current or former smokers is an independent predictor of overall cardiovascular events (13).”
From Updating ACSM's Recommendations for Exercise Preparticipation Health Screening (2015) · cites this paper as [13]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 10
- Sin, 2005, The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature, Chest, 127, 1952, 10.1378/chest.127.6.1952 · DOI
- Holman, 2010, Effect of nateglinide on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1463, 10.1056/NEJMoa1001122 · DOI · Paper page
- McMurray, 2010, Effect of valsartan on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1477, 10.1056/NEJMoa1001121 · DOI · Paper page
- Wong, 2013, Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study, Circ Heart Fail, 6, 203, 10.1161/CIRCHEARTFAILURE.112.000086 · DOI
- Bethel, 2013, A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk, Am J Cardiol, 112, 231, 10.1016/j.amjcard.2013.03.019 · DOI
- Preiss, 2012, Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial, BMJ Open, 2, e001925, 10.1136/bmjopen-2012-001925 · DOI
- Song, 2010, Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study, Diabetes Res Clin Pract, 90, 365, 10.1016/j.diabres.2010.09.010 · DOI
- Wannamethee, 2010, Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation, Diabetes Care, 33, 1990, 10.2337/dc10-0324 · DOI
- Van den Borst, 2010, Pulmonary function in diabetes: a meta-analysis, Chest, 138, 393, 10.1378/chest.09-2622 · DOI
- Qaseem, 2011, Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society, Ann Intern Med, 155, 179, 10.7326/0003-4819-155-3-201108020-00008 · DOI
Cited by
Sorted by citations
Updating ACSM's Recommendations for Exercise Preparticipation Health Screening
RIEBE, D., FRANKLIN, B. A., THOMPSON, P. D., GARBER, C. E., WHITFIELD, G. P., MAGAL, M., & PESCATELLO, L. S. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000664 · Cited by 688
“However, chronic obstructive pulmonary disease (COPD) and CVD are often comorbid because of the common risk factor of smoking, and the presence of COPD in current or former smokers is an independent predictor of overall cardiovascular events (13).”
BackgroundFranklin, B. A., Thompson, P. D., Al-Zaiti, S. S., Albert, C. M., Hivert, M.-F., Levine, B. D., Lobelo, F., Madan, K., Sharrief, A. Z., Eijsvogels, T. M. H., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000749 · Cited by 410
Metadata
- Authors
- de Barros e Silva, P. G. M., Califf, R. M., Sun, J.-L., McMurray, J. J. V., Holman, R., Haffner, S., Thomas, L., & Lopes, R. D.
- Affiliations
- Duke Medical Center (US)
- University of Glasgow (GB)
- University of Oxford (GB)
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 176
- Issue
- 3
- Pages
- 1126-1128
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W2022948296
- Cited by
- 11
- References
- 0
- Citations by year
- 2024: 1 · 2023: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 2 · 2015: 3
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- chronic obstructive pulmonary disease, cardiovascular risk, cardiovascular mortality, diabetes mellitus, prediabetes, long-term clinical outcomes, NAVIGATOR trial
- MeSH terms
- Aged, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Mortality, Risk Factors, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
